SEC Form 4 · accession 0001358403-18-000089
BELLICUM PHARMACEUTICALS, INC · BLCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory S. Naeve
Officer — Chief Business Officer
Period of report
Aug 21, 2018
Accepted (ET)
Aug 23, 2018 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001358403
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 21, 2018 | F | 1,597 | $6.74 | D | 13,403 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the number of shares withheld by and surrendered to the Issuer on August 21, 2018, to satisfy tax withholding obligations that arose in connection with the vesting of the RSUs granted to the reporting person on August 21, 2017 for 15,000 shares, of which 3,750 vested on August 21, 2018. The RSUs vest in four equal annual installments beginning August 21, 2018.
Remarks
EXHIBIT LIST: EX-24 Power of attorney